등록된 논문 143건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG HN18-12두경부식도암

  Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12

  • 저널 Cancer Res Treat. 2021 Jul;53(3):671-677.
  • 제1저자 이윤규, 장현
  • 교신저자 안명주, 황인규

• KCSG LU16-07폐암

  Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07

  • 저널 Thorac Cancer. 2020 Dec; 11(12): 3482-3489.
  • 제1저자 김미소
  • 교신저자 김범석

• KCSG BR15-10유방암

  Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL)

  • 저널 Cancer Res Treat. 2021 Jul;53(3):695-702.
  • 제1저자 이지윤
  • 교신저자 박연희

• KCSG HN18-12두경부식도암

  Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer
  study group HN 18-12

  • 저널 J Cancer Res Clin Oncol. 2020 Dec;146(12):3359-3369
  • 제1저자 박지현, 전상훈
  • 교신저자 김성배, 김범석

• KCSG HN12-12두경부식도암

  Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

  • 저널 Br J Cancer. 2020 Dec;123(12):1720-1729.
  • 제1저자 김혜련, 강한나
  • 교신저자 김태민, 조병철

• KCSG HN14-18두경부식도암

  Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma

  • 저널 Cancer. 2020 Oct 15;126(20):4521-4531
  • 제1저자 홍민희
  • 교신저자 김태민, 김혜련, 조병철

• KCSG BR15-10유방암

  Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine
  in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)

  • 저널 Cancers (Basel) . 2020 Nov 5;12(11):3265.
  • 제1저자 이수현
  • 교신저자 박연희

• KCSG UN17-16희귀암

  Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16)

  • 저널 Transl Cancer Res. 2020 May;9(5):3222-3230.
  • 제1저자 변성규, 강명주, 최윤지
  • 교신저자 김승태

• KCSG HN13-01두경부식도암

  Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)

  • 저널 BMC Cancer. 2020 Aug 27;20(1):813
  • 제1저자 이윤규
  • 교신저자 윤환중

• KCSG UN17-16희귀암

  Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer

  • 저널 Mol Clin Oncol . 2017 Jul;7(1):27-31.
  • 제1저자 정기선
  • 교신저자 김승태

678910